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Abstract Purpose: To quantify
the effects of barrier precautions and
antibiotic mixing on prevalence and
acquisition of five drug-resistant
microorganisms within a single teta-
nus intensive care unit at a tertiary
referral hospital in Ho Chi Minh City,
Vietnam. Methods: All patients
admitted within the study period were
included. After a 1-year baseline per-
iod, barrier precautions were
implemented and the single empirical
treatment ceftazidime was changed to
mixing (per consecutive patient) of
three different regimens (ceftazidime,
ciprofloxacin, piperacillin–tazobac-
tam). Markov chain modeling and
genotyping were used to determine the
effects of interventions on prevalence
levels and the relative importance of
cross-transmission and antibiotic-
associated selection. Results: A total
of 190 patients were included in year 1
(2,708 patient days, 17,260 cultures)
and 167 patients in year 2 (3,384
patient days, 20,580 cultures). In year
1, average daily prevalence rates for
methicillin-resistant Staphylococcus





K. pneumoniae, and amikacin-resis-
tant Acinetobacter species were 34.0,
61.3, 53.4, 65.7 and 57.1 %. After
intervention, ceftazidime usage
decreased by 53 %; the use of piper-
acillin–tazobactam and ciprofloxacin
increased 7.2-fold and 4.5-fold,
respectively. Adherence to hand
hygiene after patient contact was
54 %. These measures were associ-
ated with a reduction of MRSA
prevalence by 69.8 % (to 10.3 %),
mainly because of less cross-trans-
mission (88 % reduction), and of
ESBL-producing Enterobacteriaceae
prevalence by 10.3 % (non-signifi-
cantly). In contrast, prevalence levels
of the other three pathogens remained
unaffected. Conclusion: The com-
bination of simple infection control
measures and antibiotic mixing was
highly effective in reducing the prev-
alence of MRSA, but not of Gram-
negative microorganisms.
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Introduction
Nosocomial infections and health-care-associated trans-
mission of pathogens are increasingly recognized as
challenges to health care and public health in developing
countries [1–3]. Although hospital infection control
activities have increased [4], many countries struggle to
implement control policies [5]. Nevertheless, with
increased availability of intensive care unit (ICU) facilities,
infection control is becoming increasingly important [6].
Nosocomial infection is usually preceded by coloni-
zation of the patient with the infecting microorganism. As
only a minority of the colonized patients will develop
overt infections, colonization remains unnoticed in most
cases. Patients are considered to be the major exogenous
source of microorganisms, with patient to patient trans-
mission occurring through transiently colonized hands of
health-care workers. Exogenous colonization typically is
affected by infection control measures such as barrier
precautions and hand disinfection. Colonization is con-
sidered to have originated from an endogenous source
when microorganisms that are present but undetectable on
admission are allowed to grow above a certain detection
limit as a result of selective growth advantages during
antimicrobial therapy [7].
Assessing the acquisition routes of microorganisms is
essential for the design of appropriate infection control
measures. However, determination of the transmission
route requires microbiological surveillance, including
genotyping of isolates, which is costly and laborious and
requires technical expertise. In addition, application of
costly infection control measures may not be feasible due
to limited resources.
We performed a prospective study to determine the
predominant routes of acquisition of five prevalent nos-
ocomial pathogens and to determine the effects of
infection control measures on the respective rates and
routes of acquisition, after a 1-year baseline surveillance
period, in a dedicated tetanus ICU of the Hospital for
Tropical Diseases (HTD) in Ho Chi Minh City (HCMC),
Vietnam. To circumvent the well-known methodological
pitfalls associated with such a quasi-experimental
approach executed on a ward with a relatively limited
number of patients [8], we used a mathematical modeling
approach to assess the relative importance of infection
routes [9] and validated the results of the model by
genotyping of cultured microorganisms.
Materials and methods
Study setting
The HTD is a 500-bed infectious diseases hospital. The
hospital has a 15-bed ward dedicated to tetanus patients,
admitting approximately 200 patients each year. The ward
consists of a single large room. Facilities for isolation of
patients are not available.
One nurse is responsible for the care of two patients
and on average three nursing aids are present to clean
the ward and to assist nurses with procedures such as
washing of patients. Hand washing facilities consist of
four sinks on the ward and hand rub alcohol dispensers
at the end of each bed. Gloves are only used when
contact with secretions is likely to occur, e.g., during
cleaning of dirty beds. A single glove is used during
suction of a tracheostoma. Gowns are not available
and masks are not used. The ward is cleaned twice
daily by mopping the floor and disinfection of horizon-
tal surfaces using a quaternary ammonium compound
solution (HexaniosR).
Tetanus treatment includes wound cleaning and
administration of intravenous penicillin or oral metroni-
dazole, equine antitoxin, and benzodiazepines.
Tracheostomy is performed in case of acute airway
obstruction, or to facilitate mechanical ventilation.
Pneumonia, as diagnosed on the basis of increased oxygen
requirements, fever, new chest X-ray abnormalities, and
elevated white cell count, is treated with empirical anti-
microbial therapy. Therapy is adjusted on an individual
patient basis if required, following semi-quantitative
culture of tracheobronchial aspirates and sensitivity test-
ing of isolated microorganisms.
Study design
This study was designed as a prospective before–after
study over 2 years, with a baseline surveillance period
from 1 May 2004 until 30 April 2005 and an intervention
period from 1 May 2005 until 30 April 2006. While the
options for infection control measures were discussed in
the design phase of the study, the actual measures to
implement were decided upon during the second half of
the baseline period, when the surveillance and modeling
results of the first half year were available. The study was
approved by the Scientific and Ethical Committee of the
HTD who waived the need for informed consent.
Patient characteristics and clinical data
All patients admitted to the tetanus ICU were eligible
for study inclusion. Demographic data, admission data
including prior hospitalization and tetanus severity score
[10], and clinical data, including the use of devices
(tracheostoma, urinary catheter, central venous line) and
the presence of nosocomial infections, were recorded for




Surveillance cultures were taken from all patients on
admission and then twice weekly on Monday and Thursday.
Swab samples were taken from anterior nares, sputum or
tracheostomy site or interior canula, axilla, and anus and all
were inoculated onto selective agars for detection of Pseu-
domonas aeruginosa (all), gentamicin-resistant Klebsiella
pneumoniae (GRKpn), amikacin-resistant Acinetobacter
spp. (ARAc), Enterobacteriaceae producing extended
spectrum beta-lactamases (ESBL), excluding K. pneumo-
niae (ESBLE), and methicillin-resistant Staphylococcus
aureus (MRSA) (Online Resource 1). K. pneumoniae were
excluded from the surveillance of ESBLE, because GRKpn,
which are often also ESBL-positive, were reported fre-
quently in diagnostic broncheal aspirate cultures. To obtain
better insight into the acquisition routes of these isolates,
GRKpn were studied separate from other ESBLE.
Genotyping of isolates was performed after comple-
tion of the study (Online Resource 1).
Infection control measures
On the basis of the surveillance data obtained during the
first study year, a set of infection control measures, which
were considered rational, feasible, and affordable, was
implemented (Table 1).
To prevent exogenous transmission of microorgan-
isms, exchange of equipment, materials, and staff between
patients was limited by reallocation of equipment and
materials, and procedures for washing of patients were
revised to include disinfection of washing bowls after each
patient. Appropriate use of gloves and hand washing or
disinfection before and after caring for a patient was
reinforced. Teaching sessions were given by the nurse
supervisor and medical staff to all doctors, nurses, and
nurse aids in May and June 2005. Compliance with the
new measures was assessed by direct observations,
recorded on data forms, by the nurse supervisor and one of
the staff doctors in August 2005 and February 2006. Other
staff were unaware of these assessments. The results were
reported to all staff and additional teaching sessions were
given in September 2005.
At the request of the clinicians, results of MRSA
surveillance cultures were reported to the ward, but not
for the other microorganisms studied. MRSA-positive
patients had a sign displayed on their bed.
To prevent colonization with ESBLE, the empirical
antimicrobial therapy for suspected pneumonia and sepsis
was changed to include multiple classes of antimicrobial
drugs which were available in Vietnam, to reduce selec-
tive pressure of a single antimicrobial drug regimen.
Empirical treatment consisted of ceftazidime with ami-
kacin in the first year, which was changed to a per patient
rotational regimen consisting of ceftazidime, or cipro-
floxacin, or piperacillin–tazobactam, all in combination
with amikacin, because dual empirical treatment was
preferred by the treating physicians. Imipenem was used
for second-line therapy only. Antimicrobial therapy was
recorded for all patients during the study period.
Daily ward rounds continued during the first and
second study year without changes. There were no major
changes in staff numbers in the study period.
Data analysis
Because of the typically small patient populations in ICUs
(usually less than 20) and the rapid patient turnover, large
fluctuations in proportions of colonized patients occur
naturally. In addition, the dependence created by cross-
transmission of microorganisms between patients (the risk
of acquisition is influenced by the colonization status of
other patients) precludes comparison of colonization rates
before and after application of infection control measures
Table 1 Infection control
measures implemented at the
start of study year 2
Target Infection control measures
Exogenous acquisition
of microorganisms
Reinforcement of hand hygiene
Limit exchange of equipment,
materials, and staff between
patients by allocating dedicated materials
to individual patients at bedside
Revise washing procedures: allocate wash bowls
to individual patients
Measure compliance by direct observations
Exogenous acquisition
of MRSA
Reporting of results of surveillance cultures




Change in empirical antimicrobial therapy
resulting in three regimens applied
simultaneously (‘‘antibiotic mixing’’)
Measures were targeted at reducing colonization by exogenous or endogenous acquisition. The target
of each (set of) measure(s) is indicated
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using statistical methods that assume that cross-trans-
mission events occur independently (e.g., v2 test) [11]. In
order to avoid these pitfalls in statistical analysis, we used
an algorithm based on a Markov model [9] (Online
Resource 2). On the basis of days of admission and dis-
charge, days on which cultures are taken, and results of
these surveillance cultures, maximum likelihood estima-
tors (MLEs) and confidence intervals of the acquisition
parameters for endogenous (a) and exogenous (b) acqui-
sition are calculated. In addition, the daily prevalence,
number of acquisitions, and fraction of acquisitions
ascribed to each acquisition route can be estimated.
A likelihood ratio test (v2 test) was used to test whether
the acquisition parameters were significantly different
between both periods (Online Resource 2). We compared
the results of modeling with the results obtained using
conventional analysis methods. The time to acquisition of
each of the five pathogens was compared for all patients
admitted in the first (before intervention) and second
study year by constructing multivariable Cox regression
models adjusted for individual patient characteristics
(Online Resource 2).
Categorical values were compared using v2 test.
Continuous variables were expressed as medians (range)
and compared using Wilcoxon-rank sum test. For calcu-
lation of infection rates, patients admitted in the first study
year but discharged in the second study year were
included in the first year analysis. Infection rates were
calculated only for patients whose full admission period
was within the study period. Infections were considered
hospital-acquired if they occurred more than 2 days after
admission to the ICU. Device days at risk were calculated
by adding the device days until the first infection or total
number of device days if no infection occurred.
Table 2 Patient characteristics on admission and during intensive care stay, in year 1 (baseline) and year 2 (infection control measures
implemented) of study (includes only patients with admission and discharge within total study period)
Characteristica Year 1 Year 2 P valueb
Age, years (excluding neonates)
No. of patientsc 167 150
Median 38 42 0.23
Range 5–88 2–84
Neonates no. 5 (2.9) 5 (3.1)
Male sex—no./total no. (%)c 124/174 (71.3) 120/157 (76.4)
Admission from other hospital—no./total no. (%) 149/174 (85.6) 137/157 (87.3) 0.67
[48 h in other hospital—no./total no. (%)c 27/144 (18.8) 26/128 (20.3)
Tetanus Severity Scored
No. of patientsc 166 151
Median 0.0 0.0 0.007
Range -6 to 17 -6 to 20
Duration of stay (days)
No. of patients 174 161
Median 12 17 0.004
Range 1–66 1–148
No. of patient days 2,527 3,235
Patients with tracheostomy—no./total no. (%) 83/174 (47.7) 97/159 (61.0) 0.015
Total no. of tracheostomy days 1,651 2,350
No. of patients 83 97
Median 20 21 0.25
Range 1–57 1–145
Patients ventilated—no./total no. (%) 71/174 (40.8) 97/159 (61.0) 0.0002
Total no. of ventilation days 1,089 1,713
No. of patientsc 70 96
Median 16 18 0.36
Range 1–41 1–88
No. nosocomial pneumonia/1,000 ventilation days at risk 56 40 0.17
Patients with urinary catheter—no./total no. (%)c 100/165 (60.6) 109/159 (68.6) 0.14
Total no. of catheter days 1,419 1,859
No. of patientsc 94 108
Median 13.5 14.5 0.54
Range 2–63 2–85
No. urinary tract infection/1,000 catheter days at risk 12.8 15.1 0.61
a Clinical files were missing for two patients in year 2
b Determined using v2 test or Wilcoxon-rank test
c Number of patients for whom data were available
d The Tetanus Severity Score is a composite score calculated from
the total of individual scores of age, time from first symptom to
admission, difficulty breathing on admission, co-existing medical
conditions, entry site, highest blood pressure recorded during first
day in hospital, highest heart rate recorded during first day in
hospital, lowest heart rate recorded during first day in hospital, and
highest temperature recorded during first day in hospital. The score
ranges between -8 and 48 and a score C8 is predictive of death. It
is not applicable to neonates [10]
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Results
All 190 patients with tetanus were included in the baseline
surveillance period (year 1) and 167 patients in the inter-
vention period (year 2) with a total of 2,708 patient days in
year 1 and 3,384 in year 2. A total of 174 patients in year 1
(2,527 patient days) and 161 patients in year 2 (3,235
patient days) had the complete admission within the study
period. Characteristics of these patients on admission and
during treatment are presented in Table 2. A total of 863
culture sets were obtained in year 1 and 1,029 in year 2.
Forty-one culture sets (4.5 %) were missing and 18 cul-
tures failed for technical reasons in year 1; 74 culture sets
(6.7 %) were missing and 6 cultures failed in year 2.
Compliance with hand hygiene and glove use was
assessed in year 2 during 43 observation sessions with a
total of 311 interactions between staff and patients.
Adherence to hand hygiene prior to and after patient
contact was 54 %. Adherence to glove use, including
removal of gloves, was 70 %. Staff left the patient during
an activity in only 6 % of interactions.
Ceftazidime usage decreased by 53 % (95 % CI
45–60 %) in year 2. The use of piperacillin–tazobactam
and ciprofloxacin increased 7.2-fold (95 % CI 4.6–11.8)
and 4.5-fold (95 % CI 3.1–6.6), respectively (Table 3).
The use of amikacin remained unchanged. Imipenem
usage decreased by 40 % (95 % CI 26–52 %). Penicillin
was used more often for tetanus treatment in year 1
compared to year 2 (36 % decrease in year 2, 95 % CI
29–43 %), whereas metronidazole use increased in year 2
(131 %, 95 % CI 117–148 %).
The prevalence data of the five pathogens under
investigation for the entire study period are shown in
Fig. 1.
MRSA
The estimated daily prevalence of MRSA decreased by
69.8 % from 34.0 to 10.3 % (Table 4; Fig. 1d), mainly
because of a reduction in exogenous acquisition of
MRSA. According to model predictions 84 % (95 % CI
69–91 %) of the MRSA acquisitions occurring during
year 1, were from exogenous origin, which reduced to
22 % (95 % CI 0–56 %) in year 2, but the endogenous
acquisition risk per uncolonized patient per day remained
unchanged (Fig. 2). Consequently, the number of acqui-
sitions decreased from 54 in year 1 to 19 in year 2
(Table 4). Genotyping of all MRSA strains confirmed the
modeling results showing a clonal distribution of strains
cultured in year 1 compared to variable genotypes of
strains cultured in year 2 (Fig. 3).
ESBLE
The estimated daily prevalence of ESBLE decreased from
61.3 to 55.0 %, but the estimated number of acquisitions
per year increased from 87 to 100. The predominance of
the endogenous acquisition route in year 1 changed to
predominance of exogenous acquisitions in year 2, at
approaching statistical significance (p = 0.06, v2 test)
(Table 4; Fig. 2). Genotyping of strains (approximately
70 % were Escherichia coli in both years) isolated in the
first 6 months of year 1 showed a ratio between endogenous
and exogenous acquisition of 10.5:1, whereas typing of
strains isolated in the first half of the second year revealed a
ratio of 2:1 (see Online Resource 1 for criteria used).
GRKpn, P. aeruginosa, and ARAc
Analysis of GRKpn indicated endogenous acquisition as
the predominant colonization route (Table 4). The daily
prevalence and acquisition rates did not differ between
year 1 and year 2 (p = 0.14, v2 test). Analysis of
P. aeruginosa and ARAc also indicated endogenous
acquisition as the predominant colonization route, which
increased for both in year 2 (Fig. 2; Table 4). Acquisition
parameters changed for P. aeruginosa when comparing
year 1 and year 2 by v2 test (p = 0.02) but they did not for
ARAc (p = 0.14). However, the 95 % confidence
Table 3 Antibiotic usage in
study years 1 and 2 Agent Defined daily dosages





Year 1 Year 2
Ceftazidime 173 81 0.47 0.40–0.55
All 3rd-generation
cephalosporines
179 85 0.48 0.41–0.55
Ciprofloxacine 13 59 4.46 3.10–6.59
All fluoroquinolones 81 99 1.22 1.02–1.46
Piperacillin–tazobactam 8 59 7.2 4.63–11.76
Amikacin 207 205 0.99 0.88–1.11
Imipenem 80 48 0.60 0.48–0.74
Penicillin 261 167 0.64 0.57–0.71
Metronidazole 165 217 1.31 1.17–1.48
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intervals for the estimates of a and b were large for all
three pathogens in both years (Fig. 2), and these estimates
should therefore be interpreted with caution.
Comparison of modeling results with Cox regression
analysis
Multivariate regression analysis indicated a significant
increase in time to colonization in year 2 for MRSA
(p \ 0.0001) and GRKpn (p = 0.046). For MRSA this
could correctly be interpreted as an effect of enhanced
hygiene. However, Markov modeling results for GRKPn
indicated predominantly endogenous acquisition in both
year 1 and year 2, suggesting that the observed increased
time to colonization with GRKpn is unlikely to be the
result of prevention of exogenous transmission due to
improved hygiene measures. Instead, differences between
year 1 and year 2 may be the result of an increased
median length of stay (Table 2) combined with a lower
endogenous acquisition parameter in year 2 (Table 4). No
significant differences between year 1 and year 2 were
observed for the other pathogens after multivariate
regression analysis (data not shown).
Infection rates
Rates of nosocomial pneumonia and urinary tract infec-
tion were similar in year 1 and year 2 (Table 2) despite
more severe illness on admission, more device days, and
longer duration of stay, of patients in year 2 (Table 2).
Discussion
In a tetanus ICU in Vietnam with extremely high preva-
lence of a variety of antibiotic-resistant pathogens, simple
infection control measures and rotational antibiotic use
had markedly different effects on different pathogens.
The combined measures were highly effective in reducing
exogenous MRSA transmission, but failed to reduce the
prevalence of drug-resistant Gram-negative bacteria.
Using Markov chain modeling, we observed clear dif-
ferences in the predominant acquisition routes between
MRSA and Gram-negative microorganisms. MRSA was
acquired predominantly through exogenous colonization
during the baseline period, which was almost completely
controlled by the relatively simple infection control










K. pneumoniae) (e) on tetanus
intensive care unit during year 1
(May 2004–April 2005) and
year 2 (May 2005–April 2006).
Red indicates the number of
patients colonized at a given
time point, green the number of
patients uncolonized, and blue
the number of patients with
unknown colonization status,
i.e., patient days between the
last negative culture result and
the first positive culture result,
or patient days between the last
negative result and discharge
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measures installed, which did not include widely con-
sidered key measures such as patient isolation and the use
of gowns [12, 13], as these were unavailable in our set-
ting. This conclusion is based on the observed decrease in
the estimated percentage of total number of acquisitions
which were exogenous, between estimates for year 1 and
year 2. Despite the fact that the confidence intervals are
large, they are non-overlapping indicating that this dif-
ference can be considered significant. It is difficult to
assign this beneficial effect to a single control measure,
because a set of measures was introduced, including the
reporting of MRSA-positive cultures (Table 1). Unfortu-
nately, we did not measure adherence to routine hygiene
procedures, such as hand hygiene, in the first study year.
However, it is the view of the medical and nursing team
that performing observations to measure adherence fol-
lowed by feedback of data, and active involvement in
discussions, substantially contributed to increased com-
pliance to infection control measures of all staff during
the second study year, which is confirmed by the
Table 4 Number of patients colonized (includes only patients with
admission in study period) and maximum likelihood estimators for
the acquisition parameters a (endogenous acquisition) and b
(exogenous acquisition) and related quantities, for all pathogens
under study (using data obtained from all patients present on ward








Patients with a positive culture—no./total no. (%) 44/174 (25.3) 19/161 (11.8)
Patients with a positive culture on admission—no./total no. (%) 5/174 (2.9) 4/161 (2.5) 0.83
Acquisition parameter a—MLE (95 % CI) 0.005 (0.002; 0.012) 0.005 (0.002; 0.009)
Acquisition parameter b—MLE (95 % CI) 0.117 (0.079; 0.162) 0.015 (0.0; 0.055)
Estimated daily prevalence—% (95 % CI) 34.0 (33.9; 34.2) 10.3 (10.26; 10.31)
Acquisitions—estimated no. (95 % CI) 53.7 (51.8; 55.8) 18.8 (18.1; 19.8)
Exogenous acquisitions—estimated % of total no. of acquisitions (95 % CI) 83.7 (69.1; 90.9) 21.7 (0; 55.5)
ESBL-positive Enterobacteriaceae (excl. K. pneumoniae)
Patients with a positive culture–no./total no. (%) 94/174 (54.0) 90/161 (55.9)
Patients with a positive culture on admission—no./total no. (%) 22/174 (12.6) 10/161 (6.2) 0.04
Acquisition parameter a—MLE (95 % CI) 0.086 (0.043; 0.107) 0.020 (0; 0.059)
Acquisition parameter b—MLE (95 % CI) 0 (0.0; 0.085) 0.105 (0.024; 0.0173)
Estimated daily prevalence—% (95 % CI) 61.3 (61.1; 61.5) 55.0 (54.9; 55.0)
Acquisitions—estimated no. (95 % CI) 86.5 (84.4; 88.7) 100.2 (98.8; 101.8)
Exogenous acquisitions—estimated % of total no. of acquisitions (95 % CI) 0 (0; 48.2) 70.8 (17.0; 100.0)
Pseudomonas aeruginosa
Patients with a positive culture—no./total no. (%) 66/174 (37.9) 95/161 (59)
Patients with a positive culture on admission—no./total no. (%) 7/174 (4.0) 9/161 (5.6) 0.5
Acquisition parameter a—MLE (95 % CI) 0.042 (0.01; 0.073) 0.085 (0.026; 0.119)
Acquisition parameter b—MLE (95 % CI) 0.037 (0; 0.114) 0.026 (0; 0.132)
Estimated daily prevalence—% (95 % CI) 53.4 (53.2; 53.7) 66.4 (66.3; 66.5)
Acquisitions—estimated no. (95 % CI) 71.3 (68.8; 74.1) 107.6 (105.8; 109.6)
Exogenous acquisitions—estimated % of total no. of acquisitions (95 % CI) 28.8 (0; 81.5) 15.1 (0; 74.0)
Gentamicin-resistant
Klebsiella pneumoniae
Patients with a positive culture—no./total no. (%) 86/174 (49.4) 92/161 (57.1)
Patients with a positive culture on admission—no./total no. (%) 19/174 (10.9) 15/161 (9.3) 0.63
Acquisition parameter a—MLE (95 % CI) 0.102 (0.049; 0.119) 0.075 (0.031; 0.091)
Acquisition parameter b—MLE (95 % CI) 0 (0; 0.094) 0 (0; 0.087)
Estimated daily prevalence—% (95 % CI) 65.7 (65.4; 65.9) 58.4 (58.4; 58.5)
Acquisitions—estimated no. (95 % CI) 90.3 (87.7; 93.1) 100.9 (99.6; 102.5)
Exogenous acquisitions—estimated % of total no. of acquisitions (95 % CI) 0 (0; 49.8) 0 (0; 57.7)
Amikacin-resistant Acinetobacter species
Patients with a positive culture—no./total no. (%) 85/174 (48.9) 89/161 (55.3)
Patients with a positive culture on admission—no./total no. (%) 21/174 (12.1) 7/161 (4.3) 0.01
Acquisition parameter a—MLE (95 % CI) 0.047 (0.014; 0.090) 0.066 (0.005; 0.096)
Acquisition parameter b—MLE (95 % CI) 0.067 (0; 0.147) 0.025 (0; 0.143)
Estimated daily prevalence—% (95 % CI) 57.1 (56.9.7; 57.2) 60.2 (60.1; 60.3)
Acquisitions—estimated no. (95 % CI) 86.9 (84.8; 89.4) 102.5 (100.8; 104.3)
Exogenous acquisitions—estimated % of total no. of acquisitions (95% CI) 39.8 (0; 80.4) 17.0 (0; 93.6)
MLE maximum likelihood estimate
a Determined using v2 test for independent observations only
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reasonably high compliance with hand hygiene and glove
use [14] observed in year 2.
Several strategies aimed at reducing selection of
ESBL-positive and multidrug-resistant bacteria by
changing treatment regimens have been studied, including
scheduled changes to regimens considered to be less
selective [15–18], antibiotic cycling [19–21], and antibi-
otic mixing [19]. The optimal strategy is unknown
because most of these studies did not take acquisition
routes into account [11, 22]. The empirical antimicrobial
treatment regimen was changed to induce mixing of dif-
ferent antibiotic classes, aimed at reducing endogenous
colonization by reducing selective pressure. Although we
observed a reduction in endogenous ESBLE acquisition in
year 2, this was counterbalanced by a higher exogenous
acquisition rate, despite lower admission rates of ESBLE
and infection control measures targeted at reducing
exogenous colonization. As a result, only a small decrease
in the estimated daily prevalence of ESBLE was observed
despite a 50 % reduction in cephalosporin use. We
hypothesize that the increase in exogenous acquisition of
ESBLE may be related to the increased proportion of
patients with tracheostomy and receiving ventilation,
associated with admission of patients with more severe
disease in year 2 (Table 2). Nevertheless, this observation
clearly demonstrates that measures which are effective in
Fig. 2 Contour plots of the likelihood of the acquisition parameters
a (endogenous acquisition, horizontal axis) and b (exogenous
acquisition, vertical axis) for Pseudomonas aeruginosa, gentamicin-
resistant Klebsiella pneumoniae, amikacin-resistant Acinetobac-
ter spp., methicillin-resistant Staphylococcus aureus (MRSA),
extended spectrum beta-lactamase-producing Enterobacteriaceae
(excl. K. pneumoniae) (ESBL-producing Enterobacteriaceae) in
year 1 and year 2. The black dot represents the maximum likelihood
estimate (MLE), the shaded area represents the corresponding 95 %
confidence interval (CI). The line represents the parameters for
which the endogenous route and the exogenous route are equally
important. For example, the MLE of exogenous acquisition
parameter b of MRSA was 0.117 (95 % CI 0.079; 0.162) in year
1 and 0.015 (0.0; 0.055) in year 2, indicating that the probability of
exogenous acquisition of MRSA per unit of time for a given
prevalence of MRSA on the ward was 8 (0.117/0.015) times lower in
year 2 compared to year 1. In contrast, the MLEs of endogenous
acquisition parameter a were both 0.005 (95 % CI 0.002; 0.012 and
0.002; 0.009) in year 1 and year 2, indicating that the daily
probability of endogenous acquisition of MRSA remained 0.5 %
throughout the entire study period
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Fig. 3 Pulse field gel
electrophoreses analysis of all
first methicillin-resistant
Staphylococcus aureus (MRSA)
strains, isolated from patients
admitted to the tetanus ICU
during the entire study period
(May 2004–April 2006). Band
patterns were generated by
restriction enzyme digestion of
total bacterial DNA. Each row
depicts the band pattern of a
single isolate and the date of
sample collection (first column),
date of admission (second
column), and date of discharge
(third column) of the patient the
isolate was cultured from.
Identical band patterns indicate
clonality as can be expected
after exogenous transmission of
MRSA
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preventing exogenous acquisition of MRSA may not be
effective in preventing exogenous acquisition of ESBLE.
Acquisition may also result from a constant back-
ground source. One drawback of our modeling approach is
that in such a scenario acquisition would be considered as
endogenous because it would occur independently of the
prevalence of other colonized patients. However, geno-
typing isolates originating from a common source typically
yields highly similar patterns and this was not the case
when K. pneumoniae strains were typed (data not shown).
The very high prevalence of multidrug-resistant Gram-
negative microorganisms acquired through endogenous
colonization suggests high colonization rates of such
bacteria in the community, still undetected at the time of
admission to ICU. Indeed, we have observed carriage
rates of Enterobacteriaceae resistant to third-generation
cephalosporins and/or gentamicin in stool samples from
up to 90 % of healthy people in HCMC [23].
Our modeling approach enabled assessment of the
effect of infection control measures, without the need for
genotyping. Performing surveillance cultures for five
pathogens simultaneously during 2 years resulted in a very
large number of cultures. In a clinical routine setting, such
extensive assessment will rarely be indicated. Exchange of
culture and modeling results by email contributed to fea-
sibility. Our approach deserves wider application, e.g., in
settings where genotyping is not available.
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